Abstract

COVID-19 has posed high concerns concerning the development of cardiovascular and respiratory, mortality and morbidity in the affected subjects. Subjects with previous cardiovascular diseases are at higher risk of hospital acquired adverse outcomes and severe infections. Aim: The present study was aimed to assess the characteristics and prevalence of comorbidities in subjects following the COVID-19. Methods: The study assessed 110 subjects from both the gender and mean age of 54.4±11.2 years with the previous history of the COVID-19 infection to assess the assess the characteristics and prevalence of comorbidities in subjects following the COVID-19. The data gathered were analyzed statistically using the SPSS software. Results: The most common comorbidity in subjects with COVID-19 was arterial hypertension seen in 54.5% (n=60) subjects followed by obesity in 33.63% (n=37) subjects, coronary heart disease in 18.1% (n=20) subjects, and congestive heart failure in 11.8% (n=13) study subjects. Less common comorbidities recorded were chronic obstructive pulmonary disease, atrial fibrillation and chronic kidney disease. Conclusion: The present study helps in better understanding of the characteristics and prevalence of comorbidities in subjects following COVID-19 infection which has a vital role in depicting the adequate strategies for managing these comorbidities and to attain better clinical outcomes. The results of present study depict the vital role of management and identification of comorbidities in subjects affected with COVID-19 to decrease the risk associated with severity of COVID-19.

Description